Monash University Launches New App Category to Support Growing ‘App’etite for ModifyHealth’s Low-FODMAP Nationwide Meal Delivery Service.

ModifyHealth((TM)), a nationwide provider of gut-friendly, Low-FODMAP and gluten-free meals has recently been recognized by Monash University through a brand new app category highlighting companies that provide fully-prepared and delivered Low-FODMAP meals. Recommended by GI providers and dietitians alike, ModifyHealth’s meals are clinically tailored to bring relief to a variety of GI conditions such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), SIBO, and celiac disease.

ModifyHealth, a nationwide provider of gut-friendly, Low-FODMAP and gluten-free meals has recently been recognized by Monash University through a brand new app category highlighting companies that provide fully-prepared and delivered Low-FODMAP meals. Recommended by GI providers and dietitians alike, ModifyHealth’s meals are clinically tailored to bring relief to a variety of GI conditions such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), SIBO, and celiac disease.

“The Monash University FODMAP Diet app is the gold standard when it comes to helping patients understand the intricacies of the Low-FODMAP protocol and how different foods can impact their gut health. Our decision to add this new ‘Low FODMAP Certified Mealscategory is testament to the growing demand and results patients are experiencing through ModifyHealth’s simple and scientific approach to home-delivered Low-FODMAP meals” says Alan Greensmith, US Head of Commercial Development, FODMAP at Monash University. We’re incredibly excited to welcome ModifyHealth as the first company to lead this new category within our app.”

“Monash University is the birthplace of the Low-FODMAP protocol and known internationally as leading experts in IBS research. This new app category highlighting ‘Low-FODMAP Certified Meals’ assures patients, dietitians, gastroenterologists and other healthcare providers that our meals meet the guidelines to help make the FODMAP journey simple and effective” says Christine Lothen-Kline, MPH, MCHES, RD, LD, Dietitian Director for ModifyHealth.

ModifyHealth’s recipes have been developed by award-winning chefs under the direction of expert Low-FODMAP dietitian, speaker and author, Patsy Catsos, MS, RDN, LD to ensure all recipes adhere to evidence-based FODMAP guidelines and thresholds while maintaining appropriate nutritional values.

“We are passionate about ensuring positive outcomes by helping patients properly follow a Low-FODMAP protocol, says GB Pratt, Founder & CEO of ModifyHealth. “We’re honored to be the first prepared meal delivery service to earn Monash University’s certification and are excited to see this category within their app. It’s the latest step in our mission to make ‘food as medicine’ simple, effective and enjoyable for providers and patients.”

About ModifyHealth
ModifyHealth changes lives by making food as medicine simple, effective and enjoyable for providers and patients. ModifyHealth’s provider-recommended, home-delivered, Low-FODMAP, and gluten-free meals are shipped nationwide to help bring relief to common GI conditions such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), SIBO, and celiac disease where dietary modification is a recommended treatment. Meals are Monash University Low-FODMAP CertifiedTM, organic, non-GMO, delivered fully prepared and supported with expert dietitian consultations to ensure positive outcomes. For more information, please visit modifyhealth.com.

Media Contact:
Ryan Moskowitz
CBO, ModifyHealth
ryan.moskowitz@modifyhealth.com 

Total
0
Shares
Leave a Reply
Related Posts
Read More

BioIQ Adds Antibody Testing to its COVID-19 Testing Platform

BioIQ, a healthcare engagement and clinical adherence technology platform company, announces the addition of antibody testing to the company's innovative COVID-19 population health solutions, including saliva RT-PCR diagnostic testing, for health plans, employers and government agencies. The recently added enzyme-linked immunosorbent assay (ELISA) test is the preferred standard in antibody testing and uses a blood or serum sample to determine whether an immunoglobulin (IgG/IgM) antibody is present in the test subject.

E/M Group Continues its Scientific and Historical Study of Titanic

E/M Group and its affiliate, RMS Titanic, Inc., announced today the recent appointment of William Lange and Bill Sauder to serve as part of a growing research team, dedicated to further understanding RMS Titanic, its wreck site and the stories surrounding her voyage. These recent appointments are part of an overall effort by E/M Group to re-establish and re-energize the continued study of RMS Titanic through long-term site management strategies, immersive high-resolution imaging and augmented reality experiences.